ArticleJournal of diabetes investigation2018

Dipeptidyl peptidase 4 inhibitor anagliptin ameliorates hypercholesterolemia in hypercholesterolemic mice through inhibition of intestinal cholesterol transport.

Moritaka Goto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.